Bowman & Co S.C.: CMG position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bowman & Co S.C. on CMG, newest first. How the timeline and the estimate are built.
Bowman & Co S.C. held 16,621 CMG shares at 2025-12-31 per its 13F-HR filed 2026-01-23.
the latest 13F is the newest step
- period ended2025-12-3113F 16,621 sharesChange vs previous 13F -1,861 shares
0.26% of the 13F portfolio, value $614,977.
13F-HR 0002085853-26-000074 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 18,482 sharesChange vs previous 13F -3,584 shares
0.31% of the 13F portfolio, value $724,311.
13F-HR 0002085853-25-000056 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 22,066 sharesChange vs previous 13F -482 shares
0.55% of the 13F portfolio, value $1,239,009.
13F-HR 0001667731-25-000756 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 22,548 sharesChange vs previous 13F +2,808 shares
0.56% of the 13F portfolio, value $1,132,139.
13F-HR 0001667731-25-000377 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 19,740 sharesChange vs previous 13F +11,587 shares
0.61% of the 13F portfolio, value $1,190,324.
13F-HR 0001667731-25-000035 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 8,153 sharesChange vs previous 13F not available
0.25% of the 13F portfolio, value $469,779.
13F-HR 0001906275-24-000004 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).